{"transactions":[{"id":2041850,"issuer":{"id":8249,"kind":"organization","name":"Pulmatrix, Inc."},"owners":[{"id":117529,"kind":"person","name":"Batycky Richard P.","position":1,"cik":"0001646596","reported_name":"Batycky Richard P.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-01-30T21:05:40.000Z","date":"2023-01-26","kind":"grant","acquired":true,"shares":1700,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares underlying this stock option will vest and become exercisable in forty-eight (48) equal monthly installments with the first tranche vesting on January 26, 2023, provided that the reporting person is providing services to the Issuer on the applicable vesting date and subject to the terms and conditions of the Pulmatrix, Inc. Amended and Restated 2013 Employee, Director and Consultant Equity Incentive Plan."}],"balance_after":1700,"derivative":{"exercise_price":3.99,"expiration_date":"2033-01-26","underlying":"Common Stock","underlying_shares":1700},"source":{"system":"sec-edgar","filing":"0001493152-23-002913","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1574235/000149315223002913/ownership.xml","form_type":"4"}},{"id":2420870,"issuer":{"id":8249,"kind":"organization","name":"Pulmatrix, Inc."},"owners":[{"id":117529,"kind":"person","name":"Batycky Richard P.","position":1,"cik":"0001646596","reported_name":"Batycky Richard P.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2022-01-31T14:38:58.000Z","date":"2022-01-27","kind":"grant","acquired":true,"shares":22100,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares underlying this stock option will vest and become exercisable in forty-eight (48) equal monthly installments with the first tranche vesting on January 27, 2022, provided that the reporting person is providing services to the Issuer on the applicable vesting date and subject to the terms and conditions of the Pulmatrix, Inc. Amended and Restated 2013 Employee, Director and Consultant Equity Incentive Plan."}],"balance_after":22100,"derivative":{"exercise_price":0.3701,"expiration_date":"2032-01-27","underlying":"Common Stock","underlying_shares":22100},"source":{"system":"sec-edgar","filing":"0001493152-22-002678","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1574235/000149315222002678/ownership.xml","form_type":"4"}},{"id":2888262,"issuer":{"id":8249,"kind":"organization","name":"Pulmatrix, Inc."},"owners":[{"id":117529,"kind":"person","name":"Batycky Richard P.","position":1,"cik":"0001646596","reported_name":"Batycky Richard P.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2021-02-02T02:45:16.000Z","date":"2021-01-28","kind":"grant","acquired":true,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares underlying this stock option will vest and become exercisable in forty-eight (48) equal monthly installments beginning on the first monthly anniversary of the date of grant, with the first tranche vesting on January 28, 2021, provided that the reporting person is providing services to the Issuer on the applicable vesting date and subject to the terms and conditions of the Pulmatrix, Inc. Amended and Restated 2013 Employee, Director and Consultant Equity Incentive Plan."}],"balance_after":15000,"derivative":{"exercise_price":1.47,"expiration_date":"2031-01-28","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001493152-21-002322","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1574235/000149315221002322/ownership.xml","form_type":"4"}},{"id":3181426,"issuer":{"id":8249,"kind":"organization","name":"Pulmatrix, Inc."},"owners":[{"id":117529,"kind":"person","name":"Batycky Richard P.","position":1,"cik":"0001646596","reported_name":"Batycky Richard P.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2020-04-06T13:17:09.000Z","date":"2020-04-02","kind":"grant","acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares underlying this stock option will vest and become exercisable in forty-eight (48) equal monthly installments beginning on the first monthly anniversary of the date of grant, with the first tranche vesting on May 2, 2020, provided that the reporting person is providing services to the Issuer on the applicable vesting date and subject to the terms and conditions of the Pulmatrix, Inc. Amended and Restated 2013 Employee, Director and Consultant Equity Incentive Plan."}],"balance_after":10000,"derivative":{"exercise_price":1.28,"expiration_date":"2030-04-02","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0000899243-20-010273","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1574235/000089924320010273/doc4.xml","form_type":"4"}},{"id":3312336,"issuer":{"id":8249,"kind":"organization","name":"Pulmatrix, Inc."},"owners":[{"id":117529,"kind":"person","name":"Batycky Richard P.","position":1,"cik":"0001646596","reported_name":"Batycky Richard P.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2020-01-13T22:17:24.000Z","date":"2020-01-09","kind":"grant","acquired":true,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Twenty-five percent (25%) of this option will vest and become exercisable on November 1, 2020 (the \"First Vesting Date\"), and the remaining shares underlying the option will vest and become exercisable in thirty-six (36) equal monthly installments on each monthly anniversary of the First Vesting Date thereafter, provided that the reporting person is providing services to the Issuer on the applicable vesting date and subject to the terms and conditions of the Pulmatrix, Inc. Amended and Restated 2013 Employee, Director and Consultant Equity Incentive Plan."}],"balance_after":30000,"derivative":{"exercise_price":1.54,"expiration_date":"2030-01-09","underlying":"Common Stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0000899243-20-001092","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1574235/000089924320001092/doc4.xml","form_type":"4"}},{"id":4034875,"issuer":{"id":111987,"kind":"organization","name":"Acorda Therapeutics, Inc.","symbol":"ACOR"},"owners":[{"id":117529,"kind":"person","name":"Batycky Richard P.","position":1,"cik":"0001646596","reported_name":"Batycky Richard P.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Tech. Off. & Site Head"}}],"security":"Common Stock","published_at":"2018-02-26T08:25:02.000Z","date":"2018-02-22","kind":"grant","acquired":true,"shares":5197,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects the number of shares of the issuer's Common Stock that will be issued to the reporting person based on the vesting of restricted stock units that were previously awarded to the reporting person. The vesting of the shares under the restricted stock units was based on the issuer's achievement of a performance milestone that was specified at the time the restricted stock units were awarded."}],"balance_after":55513,"source":{"system":"sec-edgar","filing":"0001209191-18-013207","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1008848/000120919118013207/doc4.xml","form_type":"4"}},{"id":4335912,"issuer":{"id":111987,"kind":"organization","name":"Acorda Therapeutics, Inc.","symbol":"ACOR"},"owners":[{"id":117529,"kind":"person","name":"Batycky Richard P.","position":1,"cik":"0001646596","reported_name":"Batycky Richard P.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Tech. Off. & Site Head"}}],"security":"Employee Stock Option (right to buy)","published_at":"2017-05-03T16:16:33.000Z","date":"2017-05-01","kind":"grant","acquired":true,"shares":65000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to this option vest over two years from the May 1, 2017 grant date, with the first 25% to vest at the end of six months after the grant date and the remaining 75% to vest in equal quarterly installments over the remainder of such two year period."}],"balance_after":65000,"derivative":{"exercise_price":16.5,"expiration_date":"2027-05-01","underlying":"Common Stock","underlying_shares":65000},"source":{"system":"sec-edgar","filing":"0001209191-17-029649","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1008848/000120919117029649/doc4.xml","form_type":"4"}},{"id":4405871,"issuer":{"id":111987,"kind":"organization","name":"Acorda Therapeutics, Inc.","symbol":"ACOR"},"owners":[{"id":117529,"kind":"person","name":"Batycky Richard P.","position":1,"cik":"0001646596","reported_name":"Batycky Richard P.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Tech. Off. & Site Head"}}],"security":"Employee Stock Option (right to buy)","published_at":"2017-03-03T16:02:10.000Z","date":"2017-03-01","kind":"grant","acquired":true,"shares":11000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares subject to this option vest in equal quarterly installments over four years beginning on January 1, 2017 with the first quarterly installment vesting on April 1, 2017."}],"balance_after":11000,"derivative":{"exercise_price":27.475,"expiration_date":"2027-03-01","underlying":"Common Stock","underlying_shares":11000},"source":{"system":"sec-edgar","filing":"0001209191-17-017388","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1008848/000120919117017388/doc4.xml","form_type":"4"}},{"id":4405870,"issuer":{"id":111987,"kind":"organization","name":"Acorda Therapeutics, Inc.","symbol":"ACOR"},"owners":[{"id":117529,"kind":"person","name":"Batycky Richard P.","position":1,"cik":"0001646596","reported_name":"Batycky Richard P.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Tech. Off. & Site Head"}}],"security":"Common Stock","published_at":"2017-03-03T16:02:10.000Z","date":"2017-03-01","kind":"grant","acquired":true,"shares":4400,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Restricted shares issued under the Issuer's 2015 Omnibus Incentive Compensation Plan. The shares will vest 25% every year for four years with vest dates of December 1, 2017, December 1, 2018, December 1, 2019 and December 1, 2020."}],"balance_after":50316,"source":{"system":"sec-edgar","filing":"0001209191-17-017388","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1008848/000120919117017388/doc4.xml","form_type":"4"}},{"id":4575125,"issuer":{"id":111987,"kind":"organization","name":"Acorda Therapeutics, Inc.","symbol":"ACOR"},"owners":[{"id":117529,"kind":"person","name":"Batycky Richard P.","position":1,"cik":"0001646596","reported_name":"Batycky Richard P.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Tech. Off. & Site Head"}}],"security":"Common Stock","published_at":"2016-10-25T07:06:08.000Z","date":"2016-10-21","kind":"sale","acquired":false,"shares":2063,"price":20.2992,"value":41877.2496,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Sales pursuant to a 10b5-1 plan.  These sales are primarily intended to cover the tax liability resulting from restricted stock vesting."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $20.10 to $20.50 per share.  The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range."}],"balance_after":45916,"source":{"system":"sec-edgar","filing":"0001209191-16-146806","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1008848/000120919116146806/doc4.xml","form_type":"4"}}]}